Tech Support

TECHNICAL SUPPORT
+1.800.674.3430

This line is for technical support.
For General Enquiries please click General Contact

Blog

Welcome to CrownBio’s Blog where we share our thoughts
on the latest trends and hot stories in Cvmd

blog.png
February 13, 2019 Safety and Efficacy Testing of Anti-Obesity Drugs with NHPs Learn how NHP models provide a more human disease-relevant platform for enhanced preclinical safety and efficacy evaluation of anti-obesity agents. LEARN MORE
January 17, 2019 New Biomarkers to Detect Atrial Fibrillation Review the new data identifying brain natriuretic peptide and FGF-23 as biomarkers for detecting atrial fibrillation in ... LEARN MORE
January 10, 2019 Is Exercise the Key to a Healthy Life? Find out why exercise should be a key part of your healthy lifestyle in 2019. LEARN MORE
January 4, 2019 Selecting Preclinical Models of Diabetes Review the main features you need to consider when selecting preclinical models for type 2 diabetes (T2D) research, ... LEARN MORE
January 2, 2019 Stress Keeping You Up at Night? Blame Your HPA Axis New research into our master “circadian clock” explains why your body responds differently to stress at different times ... LEARN MORE
December 24, 2018 NASH 2018 Review: Improving Awareness and Potential New Therapies A look back at NASH over the course of 2018, with a focus on raising disease awareness and an update on clinical trial ... LEARN MORE
December 13, 2018 Obesity, Cancer Development, and Immunotherapy Response How does obesity impact cancer development and immunotherapy response? Find out in our review of cutting-edge combined oncology and metabolic disease studies. LEARN MORE
December 6, 2018 Exercise, Liver Cancer, and NAFLD Mortality Our current understanding of the mechanisms linking obesity and liver cancer is poor. Preclinical research links ... LEARN MORE
November 27, 2018 Advances in Type 1 Diabetes Research and Treatment Review the latest cutting-edge advances in type 1 diabetes including an oral anti-diabetes agent, the artificial ... LEARN MORE
October 5, 2018 Artificial Intelligence for Life Science Diagnostics There are multiple forms of artificial intelligence (AI), including deep learning, neural networks, Bayesian networks, ... LEARN MORE
September 11, 2018 Using Plasma Ceramides to Predict Coronary Artery Disease Cardiovascular disease (CVD) is the number one cause of death globally, making improved prognostic disease indicators an urgent priority. Are ceramides a potential biomarker for our risk of CVD and coronary artery disease? LEARN MORE
August 7, 2018 Preclinical Research Models of NAFLD/NASH Most preclinical models of NAFLD/NASH are limited to studying specific aspects of the disease. In this blog post, you ... LEARN MORE
August 2, 2018 Are Noninvasive Tests Enough for NAFLD/NASH Diagnosis? There is significant interest in validating strategies for the noninvasive evaluation of fibrosis in NAFLD/NASH. This ... LEARN MORE
July 31, 2018 From Pathogenesis to Treatment with NAFLD/NASH Non-alcoholic steatohepatitis (NASH) is a hot topic in 2018, with a race to the first approved treatment well under way ... LEARN MORE
July 24, 2018 Improving Cardiac Function with FTY720 – ADA 2018 Our ADA presentations this year included a collaborative poster with Pegasus Bio. The studies used our unique panel of ... LEARN MORE